
A recent study updated diagnostic protocols for spinal muscular atrophy (SMA), a neurodegenerative disorder caused by SMN1 gene mutations. Emphasizing SMA newborn screening (NBS), the study provided comprehensive recommendations for timely treatment and specialized care. However, insufficient data on adult-onset SMA diagnosis highlights the need for further research. The study underscores proactive approaches to enhance SMA diagnosis and management.
Like
Save
Share